BAJAJ BROKING

Notification close image
No new Notification messages
card image
3B Films IPO is Open!
Apply for the 3B Films IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Jayanti Sinha To Offload 1.42% Stake In Alkem Laboratories Via Block Deal

Synopsis:

Jayanti Sinha plans to offload a 1.42% stake in Alkem Laboratories via a block deal worth Rs.825 crore. The floor price is fixed at Rs.4,850 per share, nearly 3% below the current Alkem Laboratories share price of Rs.4,989.


Jayanti Sinha, a member of the promoter group of Alkem Laboratories Ltd, is expected to sell a 1.42% stake in the company through a block deal worth approximately Rs.825 crore. The transaction is scheduled to be executed on 5 June 2025. Axis Capital will act as the broker for this deal. The floor price has been set at Rs.4,850 per share, which reflects a discount of around 3% to the current Alkem Laboratories share price of Rs.4,989.00 on the BSE.

Also read: Flipkart To Sell 6% Stake In Aditya Birla Fashion For Rs.600 Crore

ALKEM LABORATORIES LTD.

Trade

4843.5-25.00 (-0.51 %)

Updated - 05 June 2025
4925.00day high
DAY HIGH
4826.50day low
DAY LOW
151598
VOLUME (BSE)

Key Takeaways

  • Seller: Jayanti Sinha (Promoter group)

  • Company: Alkem Laboratories Ltd

  • Stake Offloaded: 1.42%

  • Deal Size: Approx. Rs.825 crore

  • Floor Price: Rs.4,850 per share

  • Discount to Market Price: Nearly 3%

  • Broker: Axis Capital

  • Alkem Laboratories share price (last close): Rs.4,989.00

Also read: TPG To Sell 2.1% Stake In Tata Technologies For Rs.634 Crore

Block Deal Details

Particulars

Details

Stake Being Sold

1.42%

Deal Size

Rs.825 crore

Floor Price Per Share

Rs.4,850

Last Market Price (BSE)

Rs.4,989.00

Discount to Market Price

Around 3%

Broker Managing Transaction

Axis Capital

Company Performance In Q4FY25

In the March 2025 quarter, Alkem Laboratories reported a 4.26% year-on-year rise in net profit to Rs.306 crore, missing market estimates. Revenue grew 7.1% year-on-year to Rs.3,144 crore, falling slightly short of projections. EBITDA stood at Rs.391.5 crore, down 2.6% from last year, and lower than street expectations of Rs.499 crore.

The operating margin declined to 12.45% from 13.69% a year earlier. In India, Alkem’s business grew 6.5% year-on-year, trailing the industry’s 6.9%. However, the company’s acute therapy segment outperformed the market with 7.5% growth.

Alkem Laboratories share price closed at Rs.4,989.00 on the BSE, registering a drop of Rs.109.50 or 2.15% in the latest session, ahead of the expected block deal.

Also read: CA Dawn To Offload 10.2% Stake In Indegene Ltd Worth Rs.1,420 Crore

Source: CNBCTV18

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|